Key result
This review explores currently available pulmonary conduits, emphasizing tissue-engineered valves and percutaneous valve implantations as potential options for the ideal pediatric conduit.
This review highlights the ongoing need for an ideal pulmonary conduit in pediatric cardiac surgery, focusing on tissue engineering and percutaneous options.
Suboptimal pediatric pulmonary conduits persist; leaves open tissue-engineered and percutaneous valves as investigational options.
The limited lifespan of all currently available conduits leads to repeat operations and interventional procedures in many children. Each reoperation entails considerable risk to life, expenditure and compromised quality of life as the conduit degenerates. The ideal conduit should be available freely, inexpensive, require no anticoagulation, be resistant to infection, free from thromboembolism, have no gradients or regurgitation and have unlimited durability. This review explores various options as surgeons and researchers endeavor to develop the ideal conduit--which will fulfill all of the above-mentioned criteria. Various currently available conduits are analyzed. Special emphasis is given to tissue-engineered valves and percutaneous valve implantations.
No takes yet. Share an insight, caveat, or question.
Solomon et al. (2006) conducted a review in Pediatric patients requiring pulmonary conduits. Pulmonary conduits (including tissue-engineered and percutaneous valves) was evaluated. This review explores currently available pulmonary conduits, emphasizing tissue-engineered valves and percutaneous valve implantations as potential options for the ideal pediatric conduit.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: